Amgen : AMGN

All Amgen Articles

704 Articles

247alex | Sep 25, 2014 at 6:12 AM EDT

10 Companies Cutting the Most Jobs

Through August, planned job cuts were slightly lower than they were during the first eight months of 2013. In all,…

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

Lee Jackson | Sep 9, 2014 at 8:30 AM EDT

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…

Chris Lange | Aug 27, 2014 at 10:25 AM EDT

Rising Short Interest in Biotech Stocks

Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts.

Lee Jackson | Aug 18, 2014 at 9:00 AM EDT

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

ThinkstockMost firms we cover on Wall Street have quantitative strategies for their clients, and often they use similar formulas to…

Jon C. Ogg | Aug 1, 2014 at 10:20 AM EDT

Do Layoffs in Biotech Send the Right Message?

This week's layoff announcement by Amgen may have investors and the public starting to rethink what "being a biotech company"…

Lee Jackson | Jul 28, 2014 at 8:55 AM EDT

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…

Lee Jackson | Jul 21, 2014 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

New research reports from the biotech, health care and medical device teams at Deutsche Bank raise price targets on three…

Lee Jackson | Jul 16, 2014 at 10:15 AM EDT

4 Top Biotechs Expected to Beat Earnings Expectations

In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current…

Lee Jackson | Jul 9, 2014 at 8:40 AM EDT

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…

Jon C. Ogg | Jun 19, 2014 at 2:05 PM EDT

Will Celgene Trigger Other Biotech Stock Splits?

Celgene has decided to join the stock split game. Even though stock splits change nothing fundamentally, 24/7 Wall St. would…

Jon C. Ogg | Jun 11, 2014 at 6:50 AM EDT

Short Sellers Remain Vigilant Against Top Biotech Stocks

ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Douglas A. McIntyre | May 26, 2014 at 6:53 AM EDT

Google Top Company for Pay and Benefits

Google topped all companies in terms of best pay and benefits in a new survey by online jobs site Glassdoor.…

Jon C. Ogg | May 16, 2014 at 8:30 AM EDT

Top Biotech Stocks for Cancer Cures From Cowen

ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance…

1 … 28 29 30 31 32 … 47

Amgen : AMGN

All Amgen Articles

10 Companies Cutting the Most Jobs

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

Do Layoffs in Biotech Send the Right Message?

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

4 Top Biotechs Expected to Beat Earnings Expectations

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Will Celgene Trigger Other Biotech Stock Splits?

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Could You Retire Like Royalty in Vietnam With $400,000?

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Could You Retire Like Royalty in Vietnam With $400,000?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Could You Retire Like Royalty in Vietnam With $400,000?

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

Amgen : AMGN

All Amgen Articles

10 Companies Cutting the Most Jobs

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Rising Short Interest in Biotech Stocks

RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now

Do Layoffs in Biotech Send the Right Message?

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

4 Top Biotechs Expected to Beat Earnings Expectations

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

Will Celgene Trigger Other Biotech Stock Splits?

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Could You Retire Like Royalty in Vietnam With $400,000?

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Featured Reads

Could You Retire Like Royalty in Vietnam With $400,000?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.